Purpose: To investigate the association of red blood cell (RBC), hemoglobin (Hb), red cell distribution width-coefficient of variation (RDW-CV), and red cell distribution width-standard deviation (RDW-SD) with preoperative deep vein thrombosis (DVT) in patients undergoing total joint arthroplasty (TJA).

Methods: A total of 2059 TJA patients were enrolled. We used the ratios of RBC, Hb, RDW-CV, and RDW-SD to DVT before TJA to create the receiver operator characteristic (ROC) curve, thereby calculating the cut-off values and the area under the curve (AUC). The patients were categorized into groups based on cut-off value, and risk factors for DVT before TJA were subsequently analyzed. We included the variates that were statistically significant in the univariate analysis in the multivariate binary logistic regression analysis.

Results: Preoperative DVT occurred in 107 cases (5.20%). Based on the ROC curve, we found that the AUC for RBC, Hb, RDW-CV, and RDW-SD were 0.658, 0.646, 0.568, and 0.586, respectively. Multivariate binary regression analysis revealed that the risk of preoperative DVT in TJA patients with RBC≤3.92*10 /L, Hb≤118g/L, RDW-CV≥13.2%, and RDW-SD≥44.6fL increased 3.02 ( < 0.001, 95% confidence interval (CI) [2.0-4.54]), 2.15 ( < 0.001, 95% CI [1.42-3.24]), 1.54 ( = 0.038, 95% CI [1.03-2.3]), and 1.98 times ( = 0.001, 95% CI [1.32-2.98]), respectively. The risk of preoperative DVT in patients with corticosteroid use increased approximately 2.6 times ( = 0.002, 95% CI [1.22-5.81]).

Conclusion: We found that decreased RBC and Hb, increased RDW-CV and RDW-SD, and corticosteroid use were independent risk factors for preoperative DVT in patients undergoing TJA.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806375PMC
http://dx.doi.org/10.1177/10760296221149029DOI Listing

Publication Analysis

Top Keywords

dvt tja
12
association red
8
red blood
8
blood cell
8
preoperative deep
8
deep vein
8
vein thrombosis
8
patients undergoing
8
undergoing total
8
total joint
8

Similar Publications

Background: The adverse effects of aspirin are dose-dependent, and there is controversy surrounding the use of low-dose (LD) aspirin to prevent venous thromboembolism (VTE) following total joint arthroplasty (TJA). This meta-analysis sought to compare the efficacy and complication rate of low-dose (162 mg per day) versus high-dose (HD, 650 mg per day) aspirin after TJA surgery.

Methods: In four main databases, we searched from inception until September 2024 for articles comparing the rate of VTE following TJA(TKA/THA) using only aspirin chemoprophylaxis with different dosages.

View Article and Find Full Text PDF

Comparative studies often use the value to convey statistical significance, but fragility indices (FI) and fragility quotients (FQ) may better signify statistical strength. The use of aspirin as venous thromboembolism (VTE) chemoprophylaxis following elective arthroplasty has been debated between the orthopedic and cardiac fields. The purpose of this study was to apply both the FI and FQ to evaluate the degree of statistical fragility in the total joint arthroplasty (TJA) literature regarding aspirin (ASA) use for VTE prevention.

View Article and Find Full Text PDF

Background Total joint arthroplasty (TJA) patients on preoperative anticoagulation therapy present a challenge for adult reconstruction surgeons. The goal in managing such patients is to limit bleeding complications associated with administering the medications while preventing medical complications from withholding them. At our institution, we began a protocol in 2017 that utilizes a half-dose direct oral anticoagulant (DOAC) regimen for one week followed by resuming of the full-dose regimen in select patients who underwent TJA.

View Article and Find Full Text PDF
Article Synopsis
  • Total joint arthroplasty (TJA) can cause a lot of blood loss, making people feel weak and increasing the chances of getting infections.
  • Tranexamic acid (TXA) can help reduce this blood loss, and this study looked at how well oral TXA works compared to other ways of taking it.
  • The results showed that using oral TXA along with another method was better at lowering blood loss and the need for blood transfusions than using oral TXA alone or other methods.
View Article and Find Full Text PDF
Article Synopsis
  • Dexamethasone (DEX) is a medicine that may help reduce blood clots after knee or hip surgery in patients with a history of blood clots.
  • A study looked at over 70,000 patients who had this surgery, comparing those who received DEX with those who didn't.
  • Patients who took DEX had fewer blood clots and shorter hospital stays, but there were no differences in infections between the two groups.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!